Premenopausal women with breast cancer in the early post-partum period show molecular profiles of invasion and are associated with poor prognosis

[1]  A. Fraser,et al.  Young-Onset Breast Cancer Outcomes by Time Since Recent Childbirth in Utah , 2022, JAMA network open.

[2]  G. Hannon,et al.  Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma , 2022, Nature Communications.

[3]  P. Goss,et al.  Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes , 2021, Nature Communications.

[4]  S. Ye,et al.  Extracellular Matrix Enzymes and Immune Cell Biology , 2021, Frontiers in Molecular Biosciences.

[5]  Rebecca D. Kehm,et al.  Global breast cancer incidence and mortality trends by region, age-groups, and fertility patterns , 2021, EClinicalMedicine.

[6]  S. Loibl,et al.  The definition of pregnancy-associated breast cancer is outdated and should no longer be used. , 2021, The Lancet. Oncology.

[7]  V. McCormack,et al.  Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study. , 2020, The Lancet. Global health.

[8]  A. Kallies,et al.  Precursor exhausted T cells: key to successful immunotherapy? , 2019, Nature Reviews Immunology.

[9]  V. Borges,et al.  PD-1 Blockade During Post-partum Involution Reactivates the Anti-tumor Response and Reduces Lymphatic Vessel Density , 2019, Front. Immunol..

[10]  P. Spellman,et al.  Human Tumor-Associated Macrophage and Monocyte Transcriptional Landscapes Reveal Cancer-Specific Reprogramming, Biomarkers, and Therapeutic Targets , 2019, Cancer cell.

[11]  J. Russo,et al.  Genomic signature of parity in the breast of premenopausal women , 2019, Breast cancer research : BCR.

[12]  F. Hodi,et al.  Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade , 2019, Nature Immunology.

[13]  M. Mori,et al.  Association Between Postpartum Breast Cancer Diagnosis and Metastasis and the Clinical Features Underlying Risk , 2019, JAMA network open.

[14]  P. Spellman,et al.  Physiologically activated mammary fibroblasts promote postpartum mammary cancer. , 2017, JCI insight.

[15]  G. Eslick,et al.  The prognosis of women diagnosed with breast cancer before, during and after pregnancy: a meta-analysis , 2016, Breast Cancer Research and Treatment.

[16]  A. Olshan,et al.  Breast cancer biologic and etiologic heterogeneity by young age and menopausal status in the Carolina Breast Cancer Study: a case-control study , 2016, Breast Cancer Research.

[17]  J. Condeelis,et al.  Signatures of breast cancer metastasis at a glance , 2016, Journal of Cell Science.

[18]  E. Wherry,et al.  Molecular and cellular insights into T cell exhaustion , 2015, Nature Reviews Immunology.

[19]  V. Borges,et al.  Wound healing‐like immune program facilitates postpartum mammary gland involution and tumor progression , 2015, International journal of cancer.

[20]  V. Borges,et al.  Cyclooxygenase-2-dependent lymphangiogenesis promotes nodal metastasis of postpartum breast cancer. , 2014, The Journal of clinical investigation.

[21]  M. Clarke,et al.  Intravital multiphoton imaging reveals multicellular streaming as a crucial component of in vivo cell migration in human breast tumors , 2013, Intravital.

[22]  D. Gao,et al.  Postpartum diagnosis demonstrates a high risk for metastasis and merits an expanded definition of pregnancy-associated breast cancer , 2013, Breast Cancer Research and Treatment.

[23]  Yarong Wang,et al.  Selective gene-expression profiling of migratory tumor cells in vivo predicts clinical outcome in breast cancer patients , 2012, Breast Cancer Research.

[24]  D. Lauffenburger,et al.  Mena invasive (MenaINV) promotes multicellular streaming motility and transendothelial migration in a mouse model of breast cancer , 2011, Journal of Cell Science.

[25]  V. Borges,et al.  Epithelial and Mesenchymal Cell Biology Alternatively Activated Macrophages and Collagen Remodeling Characterize the Postpartum Involuting Mammary Gland across Species , 2010 .

[26]  Yang Dai,et al.  Gene Expression Patterns in the Human Breast after Pregnancy , 2010, Cancer Prevention Research.

[27]  L. Holmberg,et al.  Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment , 2009, PloS one.

[28]  A. Nobel,et al.  Supervised risk predictor of breast cancer based on intrinsic subtypes. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  Kay Nieselt,et al.  Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis. , 2006, Cancer research.

[30]  M. Cronin,et al.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. , 2004, The New England journal of medicine.

[31]  P. Schedin,et al.  Mammary ECM composition and function are altered by reproductive state , 2004, Molecular carcinogenesis.

[32]  John S. Condeelis,et al.  Identification and Testing of a Gene Expression Signature of Invasive Carcinoma Cells within Primary Mammary Tumors , 2004, Cancer Research.

[33]  Mats Lambe,et al.  Transient increase in breast cancer risk after giving birth: postpartum period with the highest risk (Sweden) , 2002, Cancer Causes & Control.

[34]  Tom Freeman,et al.  Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression , 2003, Breast Cancer Research.

[35]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[36]  H. Adami,et al.  Transient increase in the risk of breast cancer after giving birth. , 1994, The New England journal of medicine.